ATE22439T1 - 2-oxo-1 (((substituierte sulfonyl)amino)carbonyl) azetidine. - Google Patents

2-oxo-1 (((substituierte sulfonyl)amino)carbonyl) azetidine.

Info

Publication number
ATE22439T1
ATE22439T1 AT82102908T AT82102908T ATE22439T1 AT E22439 T1 ATE22439 T1 AT E22439T1 AT 82102908 T AT82102908 T AT 82102908T AT 82102908 T AT82102908 T AT 82102908T AT E22439 T1 ATE22439 T1 AT E22439T1
Authority
AT
Austria
Prior art keywords
alkyl
phenyl
substituted
substituted phenyl
amino
Prior art date
Application number
AT82102908T
Other languages
English (en)
Inventor
Hermann Breuer
William A Slusarchiyk
Theodor Denzel
Uwe D Treuner
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Application granted granted Critical
Publication of ATE22439T1 publication Critical patent/ATE22439T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/085—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT82102908T 1981-04-09 1982-04-05 2-oxo-1 (((substituierte sulfonyl)amino)carbonyl) azetidine. ATE22439T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25267281A 1981-04-09 1981-04-09
EP82102908A EP0062876B1 (de) 1981-04-09 1982-04-05 2-Oxo-1 (((substituierte Sulfonyl)amino)carbonyl) azetidine

Publications (1)

Publication Number Publication Date
ATE22439T1 true ATE22439T1 (de) 1986-10-15

Family

ID=22957021

Family Applications (1)

Application Number Title Priority Date Filing Date
AT82102908T ATE22439T1 (de) 1981-04-09 1982-04-05 2-oxo-1 (((substituierte sulfonyl)amino)carbonyl) azetidine.

Country Status (16)

Country Link
EP (1) EP0062876B1 (de)
JP (1) JPS57179156A (de)
AT (1) ATE22439T1 (de)
AU (1) AU561650B2 (de)
CA (1) CA1246572A (de)
DE (1) DE3273405D1 (de)
DK (1) DK162582A (de)
ES (3) ES511238A0 (de)
GR (1) GR76486B (de)
HU (1) HU187568B (de)
IE (1) IE52938B1 (de)
IL (1) IL65407A0 (de)
NZ (1) NZ199981A (de)
PH (1) PH23122A (de)
PT (1) PT74730B (de)
ZA (1) ZA821768B (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1272726C (en) * 1982-01-04 1990-08-14 2-oxo-1-(aminocarbonylaminosulfonyl- aminocarbonyl)azetidines
US4548747A (en) * 1983-05-02 1985-10-22 E. R. Squibb & Sons, Inc. 3-Acylamino-1-sulfonylaminocarbonylmethoxy-2-azetidinones
US4534896A (en) * 1983-06-13 1985-08-13 E. R. Squibb & Sons, Inc. 3-Acylamino-2-oxoazetidine-1-(β-oxopropionic acid)
US4587051A (en) * 1983-07-18 1986-05-06 E. R. Squibb & Sons, Inc. Desulfonation process for preparing 2-azetidinones
US4584132A (en) * 1983-08-09 1986-04-22 Hoffmann-La Roche Inc. 1-(N-phosphinylcarbamoyl) β-lactam antibacterial agents
US4559335A (en) * 1983-10-03 1985-12-17 E. R. Squibb & Sons, Inc. 3-Acylamino-1-carboxymethyloxy (or thio) carbonyl-2-azetidinones
US4576749A (en) * 1983-10-03 1986-03-18 E. R. Squibb & Sons, Inc. 3-Acylamino-1-carboxymethylaminocarbonyl-2-azetidinones
US4831130A (en) * 1984-05-31 1989-05-16 Hoffmann-La Roche Inc. β-lactam antibacterial agents
US4743685A (en) * 1985-09-26 1988-05-10 E. R. Squibb & Sons, Inc. 2-oxo-1-[[(substituted sulfonyl)amino]carbonyl]azetidines
EG18314A (en) * 1985-09-26 1993-02-28 Squibb & Sons Inc Process for preparing of 2-oxo-1((substituted sulfonyl)amino)carbonyl)-azitidines
WO1987007273A2 (en) * 1986-05-23 1987-12-03 The Upjohn Company N-1 substituted sulfonylaminocarbonyl, c-4 substituted monobactams
US4801705A (en) * 1986-06-23 1989-01-31 E. R. Squibb & Sons, Inc. 2-oxo-1-(((substituted sulfonyl)amino)-carbonyl)azetidines
CA1317298C (en) * 1987-03-03 1993-05-04 Upjohn Company (The) Antibiotic sulfonylaminocarbonyl activated .beta.-lactams
US4772693A (en) * 1987-07-01 1988-09-20 E. R. Squibb & Sons, Inc. 2-oxo-1-((Substituted sulfonyl)amino)-carbonyl)azetidines
US4762922A (en) * 1987-07-01 1988-08-09 Squibb Corporation 2-oxo-1-[[(substituted sulfonyl)amino]-carbonyl]azetidines
US4777252A (en) * 1987-08-13 1988-10-11 E. R. Squibb & Sons, Inc. 2-oxo-1-[[(substituted sulfonyl)amino]-carbonyl]azetidines
FI20031113A (fi) * 2003-07-29 2005-01-30 Outokumpu Oy Menetelmä ja laitteisto leijupetiuunin arinalta poistettavan materiaalin jäähdyttämiseksi
WO2005063704A1 (ja) * 2003-12-25 2005-07-14 Ono Pharmaceutical Co., Ltd. アゼチジン環化合物およびその医薬
AU2012233003B2 (en) * 2005-12-07 2014-12-18 Basilea Pharmaceutica Ag Useful combinations of monobactam antibiotics with beta-lactamase inhibitors
EP2308874B1 (de) * 2005-12-07 2013-01-23 Basilea Pharmaceutica AG Verbrückte Monobactam-Antibiotika verwendbar als Beta-Lactamase Hemmern
CA2744756C (en) 2008-12-19 2013-05-28 Pfizer Inc. Monocarbams and their use as antibacterial agent
KR20230175175A (ko) 2020-11-30 2023-12-29 소프로시네 파마슈티칼스 리미티드 알코올 사용 장애(Alcohol Use Disorder)를 치료하기 위한 화합물 및 방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2559307C2 (de) * 1975-12-31 1984-05-24 Rheinhold & Mahla Gmbh, 6800 Mannheim Verfahren und Vorrichtung zum Verkleben zweier Materialbahnen
US4195021A (en) * 1977-10-26 1980-03-25 Eli Lilly And Company 1,3-Disubstituted 2-azetidinone antibitotics
EP0021678B1 (de) * 1979-06-08 1984-11-07 Takeda Chemical Industries, Ltd. 1-Sulfo-2-azetidinon-Derivate, ihre Herstellung und pharmazeutische Zusammensetzungen

Also Published As

Publication number Publication date
ES521480A0 (es) 1984-06-01
ZA821768B (en) 1983-01-26
ES8307741A1 (es) 1983-07-01
NZ199981A (en) 1985-08-16
CA1246572A (en) 1988-12-13
ES8405369A1 (es) 1984-06-01
PT74730B (en) 1983-10-25
AU8155782A (en) 1982-10-14
ES521479A0 (es) 1984-06-01
DE3273405D1 (en) 1986-10-30
IL65407A0 (en) 1982-07-30
JPS57179156A (en) 1982-11-04
GR76486B (de) 1984-08-10
EP0062876A1 (de) 1982-10-20
PT74730A (en) 1982-05-01
IE820781L (en) 1982-10-09
AU561650B2 (en) 1987-05-14
DK162582A (da) 1982-10-10
IE52938B1 (en) 1988-04-13
JPH0372616B2 (de) 1991-11-19
EP0062876B1 (de) 1986-09-24
ES8405368A1 (es) 1984-06-01
PH23122A (en) 1989-05-05
HU187568B (en) 1986-01-28
ES511238A0 (es) 1983-07-01

Similar Documents

Publication Publication Date Title
ATE22439T1 (de) 2-oxo-1 (((substituierte sulfonyl)amino)carbonyl) azetidine.
AU1395283A (en) 1-carboxyalkanoylindoline-2-carboxylic acid esters
DE3781337D1 (de) 2-oxo-1-(((substituiertes sulfonyl)amino)-carbonyl)-azetidine.
DE3770644D1 (de) Monosulfactame.
DE3566664D1 (de) Substituted pyrazolin-5-one
ATE83779T1 (de) 2-oxo-1-(substituierte phosphorigsaeure)azetidine.
GR75173B (de)
IE821905L (en) 2-oxo-azetidines
ES8401020A1 (es) Procedimiento para la obtencion de oximcarbamatos n-sulfenilados.
ATE24181T1 (de) 2-oxo-1-(thiophosphon- oder thiophosphinsaeure)azetidine.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties